Bradley et al. found that after intranasal administration of 40 IU oxytocin, both schizophrenia patients and healthy controls showed increases in bidding motivated by preferences for both monetary and social reward, but the social reward behavior was significantly different in patients with schizophrenia compared to healthy controls. This evidence concerns the gene OXT and schizophrenia.